The Lancet
Ana Mateus is an experienced editorial professional with a strong background in scientific research and publishing. Currently serving as Executive Editor at The Lancet since April 2021, Ana previously held senior editorial roles at Springer Nature, including at Nature Cell Biology, Nature Metabolism, and Nature Communications, where responsibilities encompassed evaluating and summarizing scientific research, shaping journal strategies, and overseeing the peer review process. With a robust academic foundation, including a PhD in Cell and Developmental Biology from the University of Cambridge, Ana has also contributed to various aspects of scientific research, demonstrated through roles as a Research Associate and Postdoctoral researcher, alongside an advisory position at the TRANSMIT project.
The Lancet
The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (Oct 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. The Lancet has evolved as a family of journals but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.